J.T. Haresco

Amid a flood of news from smaller bio-pharmaceutical concerns, analysts at JMP Securities picked through some winners and losers. The firm's analysts maintained Outperform ratings Wednesday on Infinity Pharmaceuticals Inc. (NASDAQ: INFI), Impax Laboratories Inc (NASDAQ: IPXL) and...

Achillion Pharmaceuticals Inc.'s (NASDAQ: ACHN) recent interim data for its developmental hepatitis C drug is "incrementally positive," according to JMP Securities' Liisa A. Bayko. Achillion's Monday data dump is among a half-dozen drug company developments that JMP analysts commented on Tuesday....

In a report issued Thursday, JMP Securities analyst J.T. Haresco, III, PhD commented on Boston Scientific Corporation (NYSE: BSX) following its earnings report Wednesday afternoon. Although the company posted in-line fourth-quarter earnings and issued a weak guidance, the firm reiterated a Market...

In a report published Monday, JMP Securities analyst J.T. Haresco initiated coverage on Parnell Pharmaceuticals Holdings Ltd. (NASDAQ: PARN) with a Market Outperform rating and $12.00 price target. In the report, JMP Securities noted, “Parnell is a fully integrated pharmaceutical company...

On Wednesday, JMP Securities set a price target of $700, the highest on the Street, on shares of Intuitive Surgical (NASDAQ: ISRG) and upgraded the stock from Market Underperform to Market Outperform. Analyst J.T. Haresco believes a large share of the company's prior models in the United States...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Qiagen NV (NASDAQ: QGEN) with a Market Outperform rating and $30.00 price target. In the report, JMP Securities noted, “We are initiating coverage of Qiagen with a Market Outperform rating and $30 price...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Quidel (NASDAQ: QDEL) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage of Quidel at Market Perform. The company has laid out a potentially transformative game...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Organovo (NYSE: ONVO) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage on Organovo Holdings at Market Perform. Organovo is a development-stage company focused on...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Laboratory Corporation of America (NYSE: LH) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage on Laboratory Corporation of America with a Market Perform rating....

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Illumina (NASDAQ: ILMN) with a Market Outperform rating and $125.00 price target. In the report, JMP Securities noted, “We are initiating coverage on Illumina with a Market Outperform rating and establishing...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Foundation Medicine (NASDAQ: FMI) with a Market Outperform rating and $33.00 price target. In the report, JMP Securities noted, “We are initiating coverage on Foundation Medicine (FMI) with a Market...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Quest Diagnostics (NYSE: DGX) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage on Quest Diagnostics (DGX) with a Market Perform rating. DGX provides clinical...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Cepheid (NASDAQ: CPHD) with a Market Perform rating. In the report, JMP Securities noted, “We are initiating coverage of Cepheid with a Market Perform rating. The company is the market leader in the Hospital...

In a report published Wednesday, JMP Securities analyst J.T. Haresco initiated coverage on Alere (NYSE: ALR) with a Market Outperform rating and $45.00 price target. In the report, JMP Securities noted, “We are initiating coverage of Alere, a leading provider of rapid diagnostic tests, with a...